UK markets closed

Novartis AG (NVSEF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
74.38+1.38 (+1.89%)
At close: 09:54AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.49
52-week change 3-11.25%
S&P500 52-week change 3-16.34%
52-week high 393.58
52-week low 372.98
50-day moving average 383.18
200-day moving average 385.33

Share statistics

Avg vol (3-month) 344.83k
Avg vol (10-day) 3121.6k
Shares outstanding 52.18B
Implied shares outstanding 6N/A
Float 82.1B
% held by insiders 13.76%
% held by institutions 134.46%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 43.35
Forward annual dividend yield 44.42%
Trailing annual dividend rate 33.39
Trailing annual dividend yield 34.64%
5-year average dividend yield 4N/A
Payout ratio 432.92%
Dividend date 307 Mar 2018
Ex-dividend date 407 Mar 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 43.54%
Operating margin (ttm)25.14%

Management effectiveness

Return on assets (ttm)6.72%
Return on equity (ttm)39.23%

Income statement

Revenue (ttm)52.79B
Revenue per share (ttm)23.74
Quarterly revenue growth (yoy)-1.60%
Gross profit (ttm)37.44B
EBITDA 18.43B
Net income avi to common (ttm)22.98B
Diluted EPS (ttm)10.20
Quarterly earnings growth (yoy)-41.50%

Balance sheet

Total cash (mrq)19.64B
Total cash per share (mrq)9
Total debt (mrq)31.09B
Total debt/equity (mrq)49.34
Current ratio (mrq)1.38
Book value per share (mrq)28.83

Cash flow statement

Operating cash flow (ttm)14.21B
Levered free cash flow (ttm)11.68B